{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:47:32Z","timestamp":1791384452630,"version":"4.3.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation, Korea","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04719-2","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:11:26Z","timestamp":1761905486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["HDAC inhibitors restore osteoimmune balance and bone regeneration via selective MAPK modulation in inflammatory bone disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Hyewon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leewoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"4719_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/bs.apcsb.2024.10.013","volume":"144","author":"L Sapra","year":"2025","unstructured":"Sapra L, Srivastava RK. Immunotherapy in the management of inflammatory bone loss in osteoporosis. Adv Protein Chem Struct Biol. 2025;144:461\u201391.","journal-title":"Adv Protein Chem Struct Biol"},{"key":"4719_CR2","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3389\/fimmu.2019.01483","volume":"10","author":"U Steffen","year":"2019","unstructured":"Steffen U, Schett G, Bozec A. How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis. Front Immunol. 2019;10:1483.","journal-title":"Front Immunol"},{"key":"4719_CR3","doi-asserted-by":"publisher","first-page":"1385436","DOI":"10.3389\/fimmu.2024.1385436","volume":"15","author":"M Zhang","year":"2024","unstructured":"Zhang M, Liu Y, Afzali H, Graves DT. An update on periodontal inflammation and bone loss. Front Immunol. 2024;15:1385436.","journal-title":"Front Immunol"},{"issue":"6","key":"4719_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s11914-023-00824-4","volume":"21","author":"HM Torres","year":"2023","unstructured":"Torres HM, Arnold KM, Oviedo M, Westendorf JJ, Weaver SR. Inflammatory processes affecting bone health and repair. Curr Osteoporos Rep. 2023;21(6):842\u201353.","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"4719_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1053\/j.semdp.2011.02.012","volume":"28","author":"EF DiCarlo","year":"2011","unstructured":"DiCarlo EF, Kahn LB. Inflammatory diseases of the bones and joints. Semin Diagn Pathol. 2011;28(1):53\u201364.","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"4719_CR6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1152\/physrev.00036.2016","volume":"97","author":"K Okamoto","year":"2017","unstructured":"Okamoto K, Nakashima T, Shinohara M, Negishi-Koga T, Komatsu N, Terashima A, et al. Osteoimmunology: the conceptual framework unifying the immune and skeletal systems. Physiol Rev. 2017;97(4):1295\u2013349.","journal-title":"Physiol Rev"},{"key":"4719_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fimmu.2020.00058","volume":"11","author":"C Guder","year":"2020","unstructured":"Guder C, Gravius S, Burger C, Wirtz DC, Schildberg FA. Osteoimmunology: A current update of the interplay between bone and the immune system. Front Immunol. 2020;11:58.","journal-title":"Front Immunol"},{"key":"4719_CR8","doi-asserted-by":"publisher","first-page":"1512966","DOI":"10.1155\/2023\/1512966","volume":"2023","author":"D Zhang","year":"2023","unstructured":"Zhang D, Dang Y, Deng R, Ma Y, Wang J, Ao J, et al. Research progress of macrophages in bone regeneration. J Tissue Eng Regen Med. 2023;2023:1512966.","journal-title":"J Tissue Eng Regen Med"},{"key":"4719_CR9","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877:173090.","journal-title":"Eur J Pharmacol"},{"key":"4719_CR10","doi-asserted-by":"publisher","first-page":"1352946","DOI":"10.3389\/fimmu.2024.1352946","volume":"15","author":"M Luo","year":"2024","unstructured":"Luo M, Zhao F, Cheng H, Su M, Wang Y. Macrophage polarization: an important role in inflammatory diseases. Front Immunol. 2024;15:1352946.","journal-title":"Front Immunol"},{"key":"4719_CR11","doi-asserted-by":"publisher","first-page":"757318","DOI":"10.3389\/fcell.2021.757318","volume":"9","author":"J Li","year":"2021","unstructured":"Li J, Li L, Wang Y, Huang G, Li X, Xie Z, et al. Insights into the role of DNA methylation in immune cell development and autoimmune disease. Front Cell Dev Biol. 2021;9:757318.","journal-title":"Front Cell Dev Biol"},{"key":"4719_CR12","doi-asserted-by":"publisher","first-page":"611197","DOI":"10.3389\/fcell.2020.611197","volume":"8","author":"M Montecino","year":"2020","unstructured":"Montecino M, Carrasco ME, Nardocci G. Epigenetic control of osteogenic lineage commitment. Front Cell Dev Biol. 2020;8:611197.","journal-title":"Front Cell Dev Biol"},{"key":"4719_CR13","doi-asserted-by":"publisher","first-page":"1030610","DOI":"10.3389\/fimmu.2022.1030610","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Ye Y, Peng K, Zeng Z, Chen L, Zeng Y. Histones: the critical players in innate immunity. Front Immunol. 2022;13:1030610.","journal-title":"Front Immunol"},{"issue":"1","key":"4719_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41420-021-00472-6","volume":"7","author":"K Li","year":"2021","unstructured":"Li K, Han J, Wang Z. Histone modifications centric-regulation in osteogenic differentiation. Cell Death Discov. 2021;7(1):91.","journal-title":"Cell Death Discov"},{"issue":"2","key":"4719_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","volume":"52","author":"SY Park","year":"2020","unstructured":"Park SY, Kim JS. A short guide to histone deacetylases including recent progress on class II enzymes. Exp Mol Med. 2020;52(2):204\u201312.","journal-title":"Exp Mol Med"},{"key":"4719_CR16","first-page":"690901","volume":"2012","author":"PV Licciardi","year":"2012","unstructured":"Licciardi PV, Karagiannis TC. Regulation of immune responses by histone deacetylase inhibitors. ISRN Hematol. 2012;2012:690901.","journal-title":"ISRN Hematol"},{"issue":"1","key":"4719_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jcb.29137","volume":"121","author":"K Algate","year":"2020","unstructured":"Algate K, Haynes D, Fitzsimmons T, Romeo O, Wagner F, Holson E, et al. Histone deacetylases 1 and 2 Inhibition suppresses cytokine production and osteoclast bone resorption in vitro. J Cell Biochem. 2020;121(1):244\u201358.","journal-title":"J Cell Biochem"},{"key":"4719_CR18","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2147\/JIR.S447811","volume":"17","author":"XM Liu","year":"2024","unstructured":"Liu XM, Yang L, Yang QB. Advanced progress of histone deacetylases in rheumatic diseases. J Inflamm Res. 2024;17:947\u201355.","journal-title":"J Inflamm Res"},{"issue":"4","key":"4719_CR19","first-page":"971","volume":"7","author":"DM Vigushin","year":"2001","unstructured":"Vigushin DM, Ali S, Pace PE, Mirsaidi N, Ito K, Adcock I, et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res. 2001;7(4):971\u20136.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4719_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/sj.bjc.6605726","volume":"103","author":"U Lassen","year":"2010","unstructured":"Lassen U, Molife LR, Sorensen M, Engelholm SA, Vidal L, Sinha R, et al. A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor Belinostat administered in combination with carboplatin and\/or Paclitaxel in patients with solid tumours. Br J Cancer. 2010;103(1):12\u20137.","journal-title":"Br J Cancer"},{"issue":"7","key":"4719_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.18632\/oncotarget.194","volume":"1","author":"S Sikandar","year":"2010","unstructured":"Sikandar S, Dizon D, Shen X, Li Z, Besterman J, Lipkin SM. The class I HDAC inhibitor MGCD0103 induces cell cycle arrest and apoptosis in colon cancer initiating cells by upregulating Dickkopf-1 and non-canonical Wnt signaling. Oncotarget. 2010;1(7):596\u2013605.","journal-title":"Oncotarget"},{"issue":"1","key":"4719_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1073\/pnas.98.1.87","volume":"98","author":"R Furumai","year":"2001","unstructured":"Furumai R, Komatsu Y, Nishino N, Khochbin S, Yoshida M, Horinouchi S. Potent histone deacetylase inhibitors built from trichostatin A and Cyclic tetrapeptide antibiotics including Trapoxin. Proc Natl Acad Sci U S A. 2001;98(1):87\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4719_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.sbi.2019.01.004","volume":"59","author":"NJ Porter","year":"2019","unstructured":"Porter NJ, Christianson DW. Structure, mechanism, and Inhibition of the zinc-dependent histone deacetylases. Curr Opin Struct Biol. 2019;59:9\u201318.","journal-title":"Curr Opin Struct Biol"},{"issue":"6","key":"4719_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1517\/13543784.2011.577737","volume":"20","author":"Y Boumber","year":"2011","unstructured":"Boumber Y, Younes A, Garcia-Manero G. Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor. Expert Opin Investig Drugs. 2011;20(6):823\u20139.","journal-title":"Expert Opin Investig Drugs"},{"key":"4719_CR25","doi-asserted-by":"publisher","first-page":"105973","DOI":"10.1016\/j.intimp.2019.105973","volume":"77","author":"SN Cui","year":"2019","unstructured":"Cui SN, Chen ZY, Yang XB, Chen L, Yang YY, Pan SW, et al. Trichostatin A modulates the macrophage phenotype by enhancing autophagy to reduce inflammation during polymicrobial sepsis. Int Immunopharmacol. 2019;77:105973.","journal-title":"Int Immunopharmacol"},{"key":"4719_CR26","doi-asserted-by":"crossref","unstructured":"Zhang P, Tao F, Li Q, Wu S, Fu B, Liu P. 5-Azacytidine and trichostatin A enhance the osteogenic differentiation of bone marrow mesenchymal stem cells isolated from steroid-induced avascular necrosis of the femoral head in rabbit. J Biosci. 2019;44(4).","DOI":"10.1007\/s12038-019-9901-7"},{"key":"4719_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijbiomac.2015.04.008","volume":"78","author":"S Vimalraj","year":"2015","unstructured":"Vimalraj S, Arumugam B, Miranda PJ, Selvamurugan N. Runx2: Structure, function, and phosphorylation in osteoblast differentiation. Int J Biol Macromol. 2015;78:202\u20138.","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"4719_CR28","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/gb-2014-15-3-r52","volume":"15","author":"H Wu","year":"2014","unstructured":"Wu H, Whitfield TW, Gordon JA, Dobson JR, Tai PW, van Wijnen AJ, et al. Genomic occupancy of Runx2 with global expression profiling identifies a novel dimension to control of osteoblastogenesis. Genome Biol. 2014;15(3):R52.","journal-title":"Genome Biol"},{"issue":"3","key":"4719_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1089\/ten.teb.2012.0527","volume":"19","author":"TM Liu","year":"2013","unstructured":"Liu TM, Lee EH. Transcriptional regulatory cascades in Runx2-dependent bone development. Tissue Eng Part B Rev. 2013;19(3):254\u201363.","journal-title":"Tissue Eng Part B Rev"},{"key":"4719_CR30","doi-asserted-by":"crossref","unstructured":"Amarasekara DS, Kim S, Rho J. Regulation of osteoblast differentiation by cytokine networks. Int J Mol Sci. 2021;22(6).","DOI":"10.3390\/ijms22062851"},{"key":"4719_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fphar.2020.00385","volume":"11","author":"X Hu","year":"2020","unstructured":"Hu X, Yin Z, Chen X, Jiang G, Yang D, Cao Z, et al. Tussilagone inhibits osteoclastogenesis and periprosthetic osteolysis by suppressing the NF-\u03baB and P38 MAPK signaling pathways. Front Pharmacol. 2020;11:385.","journal-title":"Front Pharmacol"},{"issue":"4","key":"4719_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/rai2.12088","volume":"3","author":"P Su","year":"2023","unstructured":"Su P, Luo X, Zeng C, Zhou L. Madecassic acid suppresses osteoclast differentiation and bone resorption by inhibiting RANKL-induced NF\u2010\u03baB, JNK and NFAT signaling pathways. Rheumatol Autoimmun. 2023;3(4):220\u20139.","journal-title":"Rheumatol Autoimmun"},{"issue":"10","key":"4719_CR33","doi-asserted-by":"publisher","first-page":"11082","DOI":"10.1096\/fj.201802597RR","volume":"33","author":"D Ke","year":"2019","unstructured":"Ke D, Ji L, Wang Y, Fu X, Chen J, Wang F, et al. JNK1 regulates RANKL-induced osteoclastogenesis via activation of a novel Bcl-2-Beclin1-autophagy pathway. Faseb J. 2019;33(10):11082\u201395.","journal-title":"Faseb J"},{"issue":"47","key":"4719_CR34","doi-asserted-by":"publisher","first-page":"36410","DOI":"10.1074\/jbc.M110.142307","volume":"285","author":"JH Jun","year":"2010","unstructured":"Jun JH, Yoon WJ, Seo SB, Woo KM, Kim GS, Ryoo HM, et al. BMP2-activated Erk\/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity. J Biol Chem. 2010;285(47):36410\u20139.","journal-title":"J Biol Chem"},{"key":"4719_CR35","doi-asserted-by":"publisher","first-page":"361906","DOI":"10.1155\/2013\/361906","volume":"2013","author":"B Bai","year":"2013","unstructured":"Bai B, He J, Li YS, Wang XM, Ai HJ, Cui FZ. Activation of the ERK1\/2 signaling pathway during the osteogenic differentiation of mesenchymal stem cells cultured on substrates modified with various chemical groups. Biomed Res Int. 2013;2013:361906.","journal-title":"Biomed Res Int"},{"issue":"5","key":"4719_CR36","doi-asserted-by":"publisher","first-page":"109955","DOI":"10.1016\/j.celrep.2021.109955","volume":"37","author":"L He","year":"2021","unstructured":"He L, Jhong JH, Chen Q, Huang KY, Strittmatter K, Kreuzer J, et al. Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors. Cell Rep. 2021;37(5):109955.","journal-title":"Cell Rep"},{"issue":"1","key":"4719_CR37","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1038\/s41598-022-23721-9","volume":"13","author":"L Yang","year":"2023","unstructured":"Yang L, Guo P, Wang P, Wang W, Liu J. IL-6\/ERK signaling pathway participates in type I IFN-programmed, unconventional M2-like macrophage polarization. Sci Rep. 2023;13(1):1827.","journal-title":"Sci Rep"},{"issue":"42","key":"4719_CR38","doi-asserted-by":"publisher","first-page":"E2865","DOI":"10.1073\/pnas.1121131109","volume":"109","author":"X Chen","year":"2012","unstructured":"Chen X, Barozzi I, Termanini A, Prosperini E, Recchiuti A, Dalli J, et al. Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc Natl Acad Sci U S A. 2012;109(42):E2865\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"4719_CR39","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.4049\/jimmunol.1000482","volume":"185","author":"D Feng","year":"2010","unstructured":"Feng D, Sangster-Guity N, Stone R, Korczeniewska J, Mancl ME, Fitzgerald-Bocarsly P, et al. Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated Proinflammatory cytokine expression. J Immunol. 2010;185(10):6003\u201312.","journal-title":"J Immunol"},{"issue":"2","key":"4719_CR40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jop.12790","volume":"48","author":"J Shen","year":"2019","unstructured":"Shen J, Yin C, Jiang X, Wang X, Yang S, Song G. Aberrant histone modification and inflammatory cytokine production of peripheral CD4\u2009+\u2009T cells in patients with oral lichen planus. J Oral Pathol Med. 2019;48(2):136\u201342.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"4719_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41392-024-02030-9","volume":"9","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liang R, Li Y, Jiang L, Ma D, Luo Q, et al. Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. Signal Transduct Target Ther. 2024;9(1):340.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"4719_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41368-019-0053-2","volume":"11","author":"L Lawlor","year":"2019","unstructured":"Lawlor L, Yang XB. Harnessing the HDAC-histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering. Int J Oral Sci. 2019;11(2):20.","journal-title":"Int J Oral Sci"},{"key":"4719_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.biocel.2014.07.003","volume":"54","author":"Y Fu","year":"2014","unstructured":"Fu Y, Zhang P, Ge J, Cheng J, Dong W, Yuan H, et al. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity. Int J Biochem Cell Biol. 2014;54:68\u201377.","journal-title":"Int J Biochem Cell Biol"},{"key":"4719_CR44","doi-asserted-by":"publisher","first-page":"117043","DOI":"10.1016\/j.bone.2024.117043","volume":"181","author":"P Dashti","year":"2024","unstructured":"Dashti P, Lewallen EA, Gordon JAR, Montecino MA, Davie JR, Stein GS, et al. Epigenetic regulators controlling osteogenic lineage commitment and bone formation. Bone. 2024;181:117043.","journal-title":"Bone"},{"key":"4719_CR45","first-page":"696","volume":"7","author":"L Hu","year":"2016","unstructured":"Hu L, Yu Y, Huang H, Fan H, Hu L, Yin C, et al. Epigenetic regulation of Interleukin 6 by histone acetylation in macrophages and its role in Paraquat-Induced pulmonary fibrosis. Front Immunol. 2016;7:696.","journal-title":"Front Immunol"},{"issue":"1","key":"4719_CR46","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41392-024-01976-0","volume":"9","author":"M Chen","year":"2024","unstructured":"Chen M, Li Y, Zhang M, Ge S, Feng T, Chen R, et al. Histone deacetylase Inhibition enhances extracellular vesicles from muscle to promote osteogenesis via miR-873-3p. Signal Transduct Target Ther. 2024;9(1):256.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4719_CR47","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41419-021-04019-6","volume":"12","author":"L Ning","year":"2021","unstructured":"Ning L, Rui X, Bo W, Qing G. The critical roles of histone deacetylase 3 in the pathogenesis of solid organ injury. Cell Death Dis. 2021;12(8):734.","journal-title":"Cell Death Dis"},{"key":"4719_CR48","doi-asserted-by":"publisher","first-page":"107057","DOI":"10.1016\/j.ejps.2025.107057","volume":"208","author":"N El Omari","year":"2025","unstructured":"El Omari N, Bakrim S, Elhrech H, Aanniz T, Balahbib A, Lee LH, et al. Clinical efficacy and mechanistic insights of FDA-approved HDAC inhibitors in the treatment of lymphoma. Eur J Pharm Sci. 2025;208:107057.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"4719_CR49","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/j.ajpath.2011.01.044","volume":"178","author":"A Advani","year":"2011","unstructured":"Advani A, Huang Q, Thai K, Advani SL, White KE, Kelly DJ, et al. Long-term administration of the histone deacetylase inhibitor Vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism. Am J Pathol. 2011;178(5):2205\u201314.","journal-title":"Am J Pathol"},{"issue":"21","key":"4719_CR50","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1002\/cncr.34974","volume":"129","author":"R Parveen","year":"2023","unstructured":"Parveen R, Harihar D, Chatterji BP. Recent histone deacetylase inhibitors in cancer therapy. Cancer. 2023;129(21):3372\u201380.","journal-title":"Cancer"},{"issue":"4","key":"4719_CR51","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4155\/fmc.12.3","volume":"4","author":"BE Gryder","year":"2012","unstructured":"Gryder BE, Sodji QH, Oyelere AK. Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Future Med Chem. 2012;4(4):505\u201324.","journal-title":"Future Med Chem"},{"key":"4719_CR52","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3389\/fonc.2020.00699","volume":"10","author":"B Burke","year":"2020","unstructured":"Burke B, Eden C, Perez C, Belshoff A, Hart S, Plaza-Rojas L, et al. Inhibition of histone deacetylase (HDAC) enhances checkpoint Blockade efficacy by rendering bladder cancer cells visible for T Cell-Mediated destruction. Front Oncol. 2020;10:699.","journal-title":"Front Oncol"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04719-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04719-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04719-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:06:49Z","timestamp":1761908809000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04719-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4719"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04719-2","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project titled \u201cThe study on effects of epigenetic modifier on modulation of inflammatory response in lipopolysaccharides (LPS)-induced mouse calvaria bone resorption model\u201d was approved by the IACUC of Seoul National University on October 16, 2023 (approval number SNU-230918-4). All animal procedures were conducted in accordance with the ARRIVE guidelines and the relevant institutional regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"604"}}